Boehringer Ingelheim Pharmaceuticals, Inc.
Member Type
Associate
Organization Type
Manufacturer
Description
Value Through Innovation is Our Vision Improving the health and lives of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus is on diseases in areas with a high unmet medical need. The company therefore concentrates on developing innovative therapies that can improve and extend lives. In Animal Health, Boehringer Ingelheim is one of the world’s leading providers of vaccines, therapeutics and preventative care offering that protect animals from disease and pain. Family-owned since its foundation in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Our aim is to transform the lives of patients –across generations. This goal inspires all of our over 53,000 employees who create value through innovation. In 2022, Boehringer Ingelheim achieved net sales of 24.1 billion euros.
Contact Information
900 Ridgebury Road
Ridgefield, CT 06877-0368
http://www.boehringer-ingelheim.com(800)344-4095
Services Offered
Branded
HIV/AIDS (HIV)
Staff
-
McQuade, Mary
AD, Trade Operations, Boehringer Ingelheim Pharmaceuticals, Inc. -
Menzie, Janet
Boehringer Ingelheim Pharmaceuticals, Inc. -
Monteiro, Manuela
Trade Coordinator, Boehringer Ingelheim Pharmaceuticals, Inc. -
Mueller, Carrie
National Account Director, Boehringer Ingelheim Pharmaceuticals, Inc. -
Napoli, Thomas
AD, Security Governance Americas, Boehringer Ingelheim Pharmaceuticals, Inc. -
Nell, Connor
National Account Director, Boehringer Ingelheim Pharmaceuticals, Inc. -
Projansky, Steven
Director, Trade Operations, Boehringer Ingelheim Pharmaceuticals, Inc. -
Ratai, Lindsay
Boehringer Ingelheim Pharmaceuticals, Inc. -
Reiss, Donna
Trade & Specialty Analyst, Boehringer Ingelheim Pharmaceuticals, Inc. -
Ripka, Sheryl
Security Manager, Gainesville, GA, Boehringer Ingelheim Pharmaceuticals, Inc.